ISSN: 0271-0749

Journal Home

Journal Guideline

Journal of Clinical Psychopharmacology Q2 Unclaimed

Lippincott Williams and Wilkins Ltd. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Clinical Psychopharmacology is a journal indexed in SJR in Psychiatry and Mental Health and Pharmacology (medical) with an H index of 121. It has a price of 2083 €. It has an SJR impact factor of 0,786 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,786.

Journal of Clinical Psychopharmacology focuses its scope in these topics and keywords: efficacy, alcohol, treatment, patients, study, lithium, risk, reuptake, serotonin, syndrome, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmacology (medical) (Q2) Psychiatry and Mental Health (Q2)

Price

2083 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,786

SJR Impact factor

121

H Index

159

Total Docs (Last Year)

510

Total Docs (3 years)

2137

Total Refs

746

Total Cites (3 years)

273

Citable Docs (3 years)

1,45

Cites/Doc (2 years)

13,44

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Eating Disorders Q2
Annals of General Psychiatry Q2
Schizophrenia Research: Cognition Q2
Journal of Cognition and Development Q2
Stress: the International Journal on Biology of Stress Q2

Compare this journals

Aims and Scope

Best articles by citations

Fluvoxamine and Fluoxetine Do Not Interact in the Same Way With the Metabolism of the Enantiomers of Methadone

Muscle lithium in manic-depressive patients during lithium therapy

Fluvoxamine-Clozapine Interaction: Time-dependent?

A 2-Year, Open-Label Pilot Study of Adjunctive Chromium in Patients With Treatment-Resistant Rapid-Cycling Bipolar Disorder

Ethnicity and the Course of Tardive Dyskinesia in Outpatients Presenting to the Motor Disorders Clinic at the Maryland Psychiatric Research Center

The Advantages of Choosing Antiobsessive Therapy According to Decision-Making Functioning

Concurrent Use of Oral Contraceptives With Antidepressants for Premenstrual Syndromes

Statistics Commentary Series

Hypothalamic-Pituitary-Adrenocortical Axis Activity as a Potential Predictor for Withdrawal Symptoms in Addiction to Flupirtine, a Nonopiate Analgesic

Statistics Commentary Series

Use of High-Dose Intravenous Haloperidol in the Treatment of Agitated Cardiac Patients

SHOW MORE ARTICLES

Cerebral Monoamine Oxidase A Inhibition in Tobacco Smokers Confirmed With PET and [11C]Befloxatone

Author Index

More on Oral Contraceptives, Drug Interactions, Herbal Medicines, and Hormone Replacement Therapy

Extensive Impairment of Triazolam and Alprazolam Clearance by Short-Term Low-Dose Ritonavir

Effectiveness of Adjunctive Gabapentin in Resistant Bipolar Disorder: Is It Due to Anxious-Alcohol Abuse Comorbidity?

Weight Loss Associated With Olanzapine Treatment

Methamphetamine Self-Administration in Humans During d-Amphetamine Maintenance

Cortical Inhibitory Dysfunction in Bipolar Disorder

Randomized, Open Naturalistic, Acute Treatment of Panic Disorder With Clonazepam or Paroxetine

A Case of Drug Dependence Syndrome to Baclofen Following High-Dose Therapy

Manic Episodes Associated With Tramadol